100 related articles for article (PubMed ID: 6634770)
1. In vivo synchronization and cell kinetics-directed treatment scheduled in human tumor therapy.
Barranco SC; Townsend CM; Costanzi JJ; Guseman LF
Prog Clin Biol Res; 1983; 132C():163-70. PubMed ID: 6634770
[No Abstract] [Full Text] [Related]
2. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
Finklestein JZ; Shore N; Krivit W; Hammond D; Higgins G
Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
[No Abstract] [Full Text] [Related]
4. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
[No Abstract] [Full Text] [Related]
5. Dianhydrogalactitol in the treatment of children with primary brain tumors.
Weinblatt ME; Ortega JA; Giggins GR; Siegel SE
Cancer Treat Rep; 1981; 65(9-10):923-4. PubMed ID: 7273030
[No Abstract] [Full Text] [Related]
6. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
[No Abstract] [Full Text] [Related]
7. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
[No Abstract] [Full Text] [Related]
8. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
Helson L; Rozsa P; Hajdu E; Helson JL
Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
Stehman FB; Blessing JA; Delgado G; Louka M
Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
[No Abstract] [Full Text] [Related]
10. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
Eagan RT; Childs DS; Layton DD; Laws ER; Bisel HF; Holbrook MA; Fleming TR
JAMA; 1979 May; 241(19):2046-50. PubMed ID: 219269
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of dianhydrogalactitol in malignant glioma.
Espana P; Wiernik PH; Walker MD
Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
[No Abstract] [Full Text] [Related]
12. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
Vats TS; Lui V; Trueworthy R; van Eys J
Cancer Treat Rep; 1981; 65(1-2):121-2. PubMed ID: 6939482
[No Abstract] [Full Text] [Related]
13. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
Vogl SE; Seltzer V; Camacho F; Calanog A
Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
[TBL] [Abstract][Full Text] [Related]
14. Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol.
Bence J; Somfai-Relle S; Gáti E
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):773-80. PubMed ID: 3770035
[TBL] [Abstract][Full Text] [Related]
15. Complex evaluation of the effect of some cytostatic hexitol derivatives.
Holczinger L; Somfai-Relle S; Institoris E; Gáti E; Turi G
Oncology; 1980; 37 Suppl 1():104-8. PubMed ID: 7454197
[TBL] [Abstract][Full Text] [Related]
16. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
Stehman FB; Blessing JA; Homesley HD; Currie JL; Yordan EL
Invest New Drugs; 1984; 2(3):331-3. PubMed ID: 6511240
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of 15 cases of chronic myelogenous leukemia treated with 1,2,5,6-dianhydrodulcitol].
Huang ZG
Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):356-8. PubMed ID: 6957285
[No Abstract] [Full Text] [Related]
19. Cytokinetics of a human neuroblastoma cell line following treatment with dianhydrogalactitol.
Sordillo PP; Andreeff M; Helson L; Steinmetz J; Melamed MR
Cancer Invest; 1985; 3(4):321-5. PubMed ID: 4027754
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
Levin VA; Wheeler KT
Cancer Chemother Pharmacol; 1982; 8(1):125-31. PubMed ID: 7094198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
